Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea
· Delayed Price · Currency is KRW
25,350
+450 (1.81%)
Aug 14, 2025, 3:30 PM KST
Orum Therapeutics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -12,211 | -5,740 | 68,217 | -63,319 |
| Depreciation & Amortization | 3,052 | 2,868 | 1,771 | 1,290 |
| Other Amortization | 391.68 | 391.68 | 824.72 | 799.07 |
| Loss (Gain) From Sale of Assets | - | - | -205.25 | - |
| Loss (Gain) From Sale of Investments | -799.27 | -799.27 | 809.55 | 52.63 |
| Stock-Based Compensation | 615.42 | 781.94 | 1,170 | 786.5 |
| Other Operating Activities | 4,015 | -1,364 | 22,514 | 21,534 |
| Change in Accounts Receivable | 13.1 | -1.87 | -0.6 | - |
| Change in Accounts Payable | 164.49 | -3.45 | -850.67 | 802.53 |
| Change in Other Net Operating Assets | -7,710 | -7,415 | -5.32 | -3,037 |
| Operating Cash Flow | -12,469 | -11,282 | 94,244 | -41,092 |
| Capital Expenditures | -1,248 | -1,264 | -1,126 | -796.13 |
| Sale of Property, Plant & Equipment | - | - | 47 | - |
| Sale (Purchase) of Real Estate | - | - | 1,796 | - |
| Investment in Securities | -51,725 | -97,197 | 262.76 | 27,758 |
| Other Investing Activities | -0 | -0 | -3,405 | -265.99 |
| Investing Cash Flow | -52,973 | -98,460 | -2,426 | 26,701 |
| Long-Term Debt Repaid | - | -1,017 | -2,281 | -1,394 |
| Net Debt Issued (Repaid) | -997 | -1,017 | -2,281 | -1,394 |
| Issuance of Common Stock | 47,930 | 178.5 | - | - |
| Other Financing Activities | - | - | -145.8 | - |
| Financing Cash Flow | 46,933 | -838.32 | 23,573 | -1,394 |
| Foreign Exchange Rate Adjustments | 3,534 | 3,622 | -8.15 | -81.88 |
| Net Cash Flow | -14,975 | -106,959 | 115,383 | -15,866 |
| Free Cash Flow | -13,717 | -12,545 | 93,117 | -41,888 |
| Free Cash Flow Margin | -65.65% | -60.01% | 68.76% | -55173.99% |
| Free Cash Flow Per Share | -789.84 | -693.22 | 6184.75 | -9106.02 |
| Cash Interest Paid | 1,840 | 1,788 | 813.28 | 75.37 |
| Cash Income Tax Paid | - | -449.93 | 329.15 | 18.55 |
| Levered Free Cash Flow | - | -10,080 | 59,189 | - |
| Unlevered Free Cash Flow | - | -8,959 | 59,704 | - |
| Change in Working Capital | -7,533 | -7,420 | -856.59 | -2,235 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.